Dutch Heart Foundation grant for atrial fibrillation research

What exactly are the underlying mechanisms that lead to the development of atrial fibrillation? And what causes someone to suffer more from the consequences of this heart rhythm disorder? The EmbRACE network will investigate this under the supervision Prof. Michiel Rienstra of the University Medical Center Groningen and Prof. Uli Schotten of CARIM. The Heart Foundation is subsidizing this research with an amount of €2.5 million. It is the follow-up to the successful RACE V study.

Atrial fibrillation is the most common heart rhythm disorder. In the Netherlands, 360,000 people have atrial fibrillation; in addition, an estimated 80,000 people who do not yet know this about themselves. It can lead to complications such as stroke, heart failure and death. The risk of this increases if someone suffers more from the consequences of atrial fibrillation. It is therefore important to prevent this.

Addressing the underlying risk factors and disease processes is a key goal of the new research. The underlying mechanisms for the onset and progression of atrial fibrillation are complex and not yet fully understood. They may be important for the treatment of atrial fibrillation. Although it is not yet known exactly how the bosom becomes diseased, it is already known that high blood pressure, obesity, heart failure and diabetes are important risk factors. The research will therefore map out the various underlying mechanisms of atrial fibrillation, both in men and women.

More information about the research can be found here: https://www.mumc.nl/actueel/nieuws/25-miljoen-euro-voor-eerder-en-beter-behandelen-van-boezemfibrilleren and https://nieuws.umcg.nl/w/2-5-miljoen-subsidie-hartstichting-voor-boezemfibrilleren-onderzoek

Overview